Trauma and post-traumatic stress disorder (PTSD) are complex conditions that can affect mental and emotional health in many ways. While established treatments help many people, some continue to experience symptoms despite treatment. This has led researchers to investigate additional approaches, including ketamine.
In this article, we look at emerging research involving ketamine and PTSD, along with some of the limitations and considerations surrounding its use.
Trauma can lead to symptoms such as intrusive memories, nightmares, anxiety, avoidance, changes in mood, and heightened reactions to perceived threats. PTSD is a specific psychiatric diagnosis that can develop following exposure to a traumatic event and involves a defined pattern of symptoms over time.
Ketamine is a dissociative anesthetic that has been used for decades in medical settings. Ketamine is not FDA-approved for PTSD or for any psychiatric disorder. Its use in psychiatric treatment is off-label.
Researchers have studied ketamine in people with PTSD and other trauma-related symptoms, but questions remain about who may benefit, how long effects may last, appropriate treatment protocols, and the role ketamine may have alongside established PTSD treatments.
Ketamine affects the glutamate system through NMDA receptor antagonism. Research has also examined its relationship to neuroplasticity, the brain’s ability to adapt and form new neural connections. The clinical significance of these effects in PTSD continues to be studied.
Ketamine has also been studied alongside psychotherapy. Some treatment models incorporate preparation, therapeutic support, or psychotherapy before, during, or after ketamine administration. Research has not established that adding psychotherapy to ketamine produces superior outcomes for every patient or condition, and approaches vary considerably across clinical settings and studies.
Ketamine treatment is not appropriate for everyone. Medical history, psychiatric history, current medications, treatment goals, and other individual factors should be evaluated before treatment is considered.
Ketamine also carries potential risks and side effects, including dissociation, sedation, changes in blood pressure, perceptual changes, respiratory depression, and the potential for abuse or misuse. When used clinically, appropriate screening, medical supervision, and monitoring are needed.
Research into ketamine and PTSD is ongoing. Current findings have generated interest in its potential role in psychiatric care, but ketamine should not be considered an established or FDA-approved treatment for PTSD.
For people experiencing trauma-related symptoms or PTSD, treatment decisions should be made with a qualified healthcare professional based on the individual’s symptoms, history, current care, and available evidence.